Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets

Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets

Androgen receptor (AR) is a male sex steroid-activated transcription factor (TF) that plays a critical role in prostate cancers, including castration-resistant prostate cancers (CRPC) that typically express amplified levels of the AR. CRPC-derived VCaP cells display an excessive number of chromatin...

Full description

Bibliographic Details
Main Authors:	Toropainen, Sari, Niskanen, Einari A., Malinen, Marjo, Sutinen, Päivi, Kaikkonen, Minna U., Palvimo, Jorma J.
Format:	Online
Language:	English
Published:	Nature Publishing Group 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027586/

Similar Items

Global SUMOylation on active chromatin is an acute heat stress response restricting transcription
by: Niskanen, Einari A., et al.
Published: (2015)

SUMOylation modulates the transcriptional activity of androgen receptor in a target gene and pathway selective manner
by: Sutinen, Päivi, et al.
Published: (2014)

SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin
by: Toropainen, Sari, et al.
Published: (2015)

Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells
by: Lindqvist, Julia, et al.
Published: (2015)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
by: Chuu, Chih-Pin, et al.
Published: (2011)

Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
by: Decker, Keith F., et al.
Published: (2012)

Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies
by: Moilanen, Anu-Maarit, et al.
Published: (2015)

Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases
by: Zhang, Xiaotun, et al.
Published: (2011)

The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer
by: Gunter, Jennifer H., et al.
Published: (2012)

Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer
by: Kobayashi, Takashi, et al.
Published: (2013)

Abiraterone Acetate: Targeting Persistent Androgen Dependence in Castration-Resistant Prostate Cancer
by: Harshman, Lauren C., et al.
Published: (2013)

Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
by: Stein, Mark N, et al.
Published: (2014)

Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
by: Lallous, Nada, et al.
Published: (2013)

Inhibiting androgen receptor nuclear entry in castration-resistant prostate cancer
by: Pollock, Julie A., et al.
Published: (2016)

Persistent androgen receptor addiction in castration-resistant prostate cancer
by: Schweizer, Michael T., et al.
Published: (2015)

Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
by: Perner, Sven, et al.
Published: (2015)

Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer
by: Schalken, Jack, et al.
Published: (2015)

Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma.
by: Westin, P., et al.
Published: (1995)

Registered report: the androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man
by: Chronscinski, Denise, et al.
Published: (2015)

LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer
by: Zhang, Ali, et al.
Published: (2015)

SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas
by: Compagno, Daniel, et al.
Published: (2007)

Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis
by: Yi, Renliang, et al.
Published: (2016)

Uncovering the Roles of miRNAs and Their Relationship with Androgen Receptor in Prostate Cancer
by: ChunJiao, Song, et al.
Published: (2014)

The androgen receptor can signal through Wnt/β-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens
by: Schweizer, Liang, et al.
Published: (2008)

Dominant-Negative Androgen Receptor Inhibition of Intracrine Androgen-Dependent Growth of Castration-Recurrent Prostate Cancer
by: Titus, Mark A., et al.
Published: (2012)

Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy
by: Kim, Yejin, et al.
Published: (2016)

Complete androgen insensitivity syndrome caused by a deep intronic pseudoexon-activating mutation in the androgen receptor gene
by: Känsäkoski, Johanna, et al.
Published: (2016)

Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer
by: Berdel, Bozena, et al.
Published: (2012)

Surgical castration efficiently delays the time of starting a systemic chemotherapy in castration-resistant prostate cancer patients refractory to initial androgen-deprivation therapy
by: Kang, Minyong, et al.
Published: (2015)

The AhR Ligand, TCDD, Regulates Androgen Receptor Activity Differently in Androgen-Sensitive versus Castration-Resistant Human Prostate Cancer Cells
by: Ghotbaddini, Maryam, et al.
Published: (2015)

Androgen Suppresses the Proliferation of Androgen Receptor-Positive Castration-Resistant Prostate Cancer Cells via Inhibition of Cdk2, CyclinA, and Skp2
by: Kokontis, John M., et al.
Published: (2014)

Correction: Androgen Suppresses the Proliferation of Androgen Receptor-Positive Castration-Resistant Prostate Cancer Cells via Inhibition of Cdk2, CyclinA, and Skp2
Published: (2014)

Inhibition of NF-kappa B signaling restores responsiveness of castrate resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor variants expression
by: Jin, Renjie, et al.
Published: (2014)

Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer
by: Rehman, Yasser, et al.
Published: (2012)

Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
by: Hörnberg, Emma, et al.
Published: (2011)

Inhibition of Glycogen Synthase Kinase-3β Counteracts Ligand-Independent Activity of the Androgen Receptor in Castration Resistant Prostate Cancer
by: Schütz, Stefanie V., et al.
Published: (2011)

Androgen Receptor Phosphorylation at Serine 308 and Serine 791 Predicts Enhanced Survival in Castrate Resistant Prostate Cancer Patients
by: McCall, Pamela, et al.
Published: (2013)

Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer
by: Pezaro, C, et al.
Published: (2013)

Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer
by: Tinzl, Martina, et al.
Published: (2013)

Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer
by: Kregel, Steven, et al.
Published: (2013)